Volume 37, Issue 7 pp. 2902-2914
RESEARCH ARTICLE

Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS/AMPK/mTOR pathway

Luping Wang

Luping Wang

College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, People's Republic of China

Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China

Search for more papers by this author
Haote Han

Haote Han

College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, People's Republic of China

Search for more papers by this author
Yue Feng

Yue Feng

Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China

Search for more papers by this author
Jiahui Ma

Jiahui Ma

Marine Science College, Zhejiang Ocean University, Zhoushan, Zhejiang, People's Republic of China

Search for more papers by this author
Zhuo Han

Zhuo Han

Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China

Search for more papers by this author
Ruyi Li

Ruyi Li

College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, People's Republic of China

Search for more papers by this author
Wei Zhu

Wei Zhu

Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China

Search for more papers by this author
Shouxin Li

Shouxin Li

Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China

Search for more papers by this author
Jingkui Tian

Corresponding Author

Jingkui Tian

Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China

Correspondence

Lin Zhang, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, People's Republic of China.

Email: [email protected]

Jingkui Tian, Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.

Email: [email protected]

Search for more papers by this author
Lin Zhang

Corresponding Author

Lin Zhang

College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, People's Republic of China

Correspondence

Lin Zhang, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, People's Republic of China.

Email: [email protected]

Jingkui Tian, Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.

Email: [email protected]

Search for more papers by this author
First published: 03 March 2023

Luping Wang, Haote Han, and Yue Feng all equally contributed to this study.

Abstract

Capilliposide B (CPS-B), a novel oleanane triterpenoid saponin derived from Lysimachia capillipes Hemsl, is a potent anticancer agent. However, its anticancer mechanism remains elusive. In the present study, we demonstrated the potent anti-tumor activity and molecular mechanism of CPS-B both in vitro and in vivo. Proteomic analysis using isobaric tags for relative and absolute quantitation techniques suggested that CPS-B modulated autophagy in prostate cancer (PC). Moreover, Western blotting showed that both autophagy and epithelial–mesenchymal transition occurred place after CPS-B treatment in vivo, which was also proven in PC-3 cancer cells. We deduced that CPS-B inhibited migration by inducing autophagy. We examined the accumulation of reactive oxygen species (ROS) in cells, and in downstream pathways, LKB1 and AMPK were activated while mTOR was inhibited. Transwell experiment results showed that CPS-B inhibited the metastasis of PC-3 cells and that this effect was significantly attenuated after pretreatment with chloroquine, indicating that CPS-B inhibited metastasis via autophagy induction. Altogether, these data suggest that CPS-B is a potential therapeutic agent for cancer treatment that acts by inhibiting migration through the ROS/AMPK/mTOR signaling pathway.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that supports the findings of this study are available in the supplementary material of this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.